Investigator Highlights

Dr. Aaron Meyer Identifies Combination Therapies for Lung Cancer

Aaron Meyer, Ph.D., a CSBC investigator at the University of California, Los Angeles (UCLA), uses systems approaches to improve the development of new drugs for cancer patients. His lab combines biological experiments with data-driven models to identify effective drug combinations for lung cancer. Models allow him to think about biology in an innovative way, define hypotheses, and communicate his findings.

Link to Investigator Highlight